Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 1460Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
OPINION
Year : 2013  |  Volume : 4  |  Issue : 4  |  Page : 196-198

Causality assessment: A casualty of compensation?


Clininvent Research Pvt. Ltd, Marol Naka, Andheri (East), Mumbai, Maharashtra, India

Correspondence Address:
Arun Bhatt
Clininvent Research Pvt. Ltd., A-302, Everest Chambers, Marol Naka, Andheri - Kurla Road, Andheri (East), Mumbai - 400 059, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2229-3485.120166

Rights and Permissions

Recent Indian rule on compensation for any injury or death of the subject in a clinical trial, has generated a lot of discussion on its impact on clinical trials in India. The legal process in the compensation rule is based on the causality assessment. However, it ignores the scientific basis of causality assessment. This could have far reaching consequences on (1) science of causality assessment and (2) safety assessment of a new drug under clinical development. There is a need to bring clarity on causality assessment process within the compensation rules to balance the ethical need of human subject protection and the scientific requirements of safety assessment.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1972    
    Printed60    
    Emailed0    
    PDF Downloaded2285    
    Comments [Add]    
    Cited by others 2    

Recommend this journal